 |
|
Simvastatin -- For hearts and minds?
July 19, 2007Statins are not all equal when it comes to their potential to guard against dementia, according to a study published in the online open access journal BMC Medicine. Statins are cholesterol-lowering drugs used by those with heart disease. The new findings suggest that simvastatin is associated with a lower incidence of dementia and Parkinson's disease. Disagreement over whether statins could guard against these conditions has meant the benefits to dementia sufferers to date have been unclear.
An international team led by Benjamin Wolozin, MD, at Boston University School of Medicine used data from the US Veterans Affairs Database, which contains diagnostic, medication and demographic information on 4.5 million subjects. The researchers used statistical models to compare different statins, looking at data on over 700,000 simvastatin users and more than 50,000 atorvastatin users. The team targeted those aged 65 or over with no prior diagnosis of Alzheimer's disease, who had been taking statins for at least seven months.
The researchers found that for subjects aged 65 and over, simvastatin was linked with a significantly reduced number of cases of dementia and Parkinson's disease". The researchers also made the surprising finding that not all statins are equal when it comes to dementia or Parkinson's disease. A small reduction in dementia cases was seen among those who regularly take atorvastatin, which did not reach a level of statistical significance. Lovastatin was not found to have any significant effect on dementia, and neither atorvastatin nor lovastatin were associated with a reduction in the number of cases of Parkinson's disease.
"The strength of reduction of incidence of dementia observed with simvastatin is striking," the authors write. Further studies should confirm that it is simvastatin's biological mode of action rather than a statistical bias at work. Previous research has studied whether statin treatment is beneficial for dementia sufferers or those at risk of dementia, but such research has lead to some conflicting results. The current study gives more reliable results as it has considerable statistical power and incorporates existing data to investigate dementia and Parkinson's disease comprehensively.
BioMed Central
"The strength of reduction of incidence of dementia observed with simvastatin is striking," the authors write. Further studies should confirm that it is simvastatin's biological mode of action rather than a statistical bias at work. Previous research has studied whether statin treatment is beneficial for dementia sufferers or those at risk of dementia, but such research has lead to some conflicting results. The current study gives more reliable results as it has considerable statistical power and incorporates existing data to investigate dementia and Parkinson's disease comprehensively.
BioMed Central
Statins Current Events and Statins News RSSBad cholesterol inhibits the breakdown of peripheral fat
he so called bad cholesterol (LDL) inhibits the breakdown of fat in cells of peripheral deposits, according to a study from the Swedish medical university Karolinska Institutet. The discovery reveals a novel function of LDL as a regulator of fat turnover besides its well-established detrimental effects in promoting atherosclerosis.
Vitamin C lowers levels of heart disease biomarker, finds study, adds to debate of health benefits
A new study led by researchers at the University of California, Berkeley, adds to the evidence that vitamin C supplements can lower concentrations of C-reactive protein (CRP), a central biomarker of inflammation that has been shown to be a powerful predictor of heart disease and diabetes.
MSU researcher studies ties between cholesterol drugs, muscle problems
A Michigan State University researcher is studying whether the most popular class of cholesterol-lowering drugs may cause muscle problems in users.
Researchers discover new risk factor for cardiovascular disease, and a way to control it
A team of international researchers - including scientists from the McGill University Health Centre (MUHC) and McGill University - have discovered that having high levels of particular protein puts patients at increased risk of developing cardiovascular disease.
Aspirin does not prevent heart attacks in patients with diabetes
Taking regular aspirin and antioxidant supplements does not prevent heart attacks even in high risk groups with diabetes and asymptomatic arterial disease, and aspirin should only be given to patients with established heart disease, stroke or limb arterial disease.
Statins may prevent miscarriages
Hospital for Special Surgery researchers have found that statins may be able to prevent miscarriages in women who are suffering from pregnancy complications caused by antiphospholipid syndrome (APS), according to a study in mice.
New devices used to reduce arterial occlusions, provide cardiac support, highlighted at TCT 2008
Research results highlighting three new devices used to reduce blockages in peripheral and coronary arteries and to provide cardiac support will be presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF).
Drug may reduce coronary artery plaque
Research presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF), suggests that olmesartan, a drug commonly used to treat high blood pressure, may play a role in reducing coronary plaque.
LIAI launches new division to look at novel approaches to heart disease and inflammation
While cholesterol-lowering drugs and new technologies have significantly advanced the nation's battle against heart disease, it continues to rank as the No. 1 killer of U.S. men and women. But if researchers at the La Jolla Institute for Allergy & Immunology (LIAI) have their way, the body's immune system will become an important player in reducing heart disease.
Will screening for cardiovascular problems be effective?
Last week the government in England closed its consultation on the effectiveness of vascular checks for high-risk individuals aged 40-74, to be rolled out in 2009-10, but will this strategy be worthwhile? Experts debate the issue on bmj.com today.
More Statins Current Events and Statins News Articles
 | What You Must Know About Statin Drugs & Their Natural Alternatives by Jay S. Cohen |
 | Statin Drugs Side Effects and the Misguided War on Cholesterol by M.D. Duane Graveline If you are on a statin drug or are thinking of going on a statin, this fully referenced book, Statin Drug Side Effects, is a "must read" for you. The unacceptable legacy of statin drug use at today's high doses is a trail of chronic aches and pains, numbness, weakness, confusion, fatigue, shortness of breath and even heart failure in hordes of unsuspecting victims. Only by knowing this... |
 | Natural Alternatives to Lipitor, Zocor & Other Statin Drugs: What to Use And Do to Help Lower Your Bad Cholesterol (Square One Health Guides) by Jay S. Cohen |
 | Statin Drugs (4 One Hour Interviews) by Dr. Stan Monteith, Dr. Russell Blaylock, Bill Sardi, Dr. Ray Strand, Shane Ellison "Statin Drugs" The drug companies are trying to convince us we must lower our cholesterol level below 200, preferably below 170. Is that wise? If you lower your cholesterol level, will you live longer? What do the scientific studies reveal? When will the mistaken idea that cholesterol is the primary cause of heart attacks and strokes finally be discarded into the trash bin of unproven medical... |
 | Statins: Understanding Clinical Use by Jawahar L. Mehta STATINS: Understanding Clinical Use was written with you-the busy practitioner-in mind. It covers the class of drugs as a whole, discusses the benefits of statin use, and offers future perspectives on ancillary drug actions beyond cholesterol lowering. Leading expert Jawahar Mehta, MD offers you top-notch guidance based on his research and extensive clinical experience-all in one compact source... |
 | Cholesterol Down: Ten Simple Steps to Lower Your Cholesterol in Four Weeks--Without Prescription Drugs by Janet Brill Take Control of Your Cholesterol— Without DrugsIf you are one of the nearly 100 million Americans struggling with high cholesterol, then Dr. Janet Brill offers you a revolutionary new plan for taking control of your health—without the risks of statin drugs. With Dr. Brill’s breakthrough Cholesterol Down Plan, you simply add nine “miracle foods” to your regular diet and thirty minutes of... |
 | Statins: The HMG CoA Reductase Inhibitors in Perspective Building upon the foundation set in the first edition, Statins: The HMG-CoA Reductase Inhibitors in Perspective examines existing and emerging statins and their beneficial effectiveness in reducing serum cholesterol. The breadth of coverage and depth of information in this book provide an authoritative guide to statins from their discovery through the major clinical trials to the present and... |
| Statins show promise for chemoprevention of melanoma: established safety profiles.(Clinical Rounds): An article from: Family Practice News by Diana Mahoney This digital document is an article from Family Practice News, published by International Medical News Group on June 15, 2004. The length of the article is 572 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation... | |
| Radio Liberty: Statin Drugs (4 Disc Set) by Dr. Stanley "Stan" Monteith, Dr. Russell Blaylock, Bill Sardi, Dr. Ray Strand, Shane Ellison There is much that is still not understood about statins, and it is increasingly apparent that they have a dark side. The major adverse effect of statins is muscle weakness and degradation, called myopathy or rhabdomyolysis, which can range from mild to severe. Understand that among low risk patients, the benefit-to-risk ratio associated with statin use is also lower. Indeed, in low-risk... |
 | Statins in General Practice: Pocketbook by Allan Gaw No member of the primary care team can afford to be indifferent to the tremendous developments that have taken place in the areas of coronary heart disease and vascular disease prevention. This new edition of Statins in General Practice includes data from the major new clinical trials. This short book contains everything that the general practitioner or practice nurse needs to know to use statins... |
| © 2008 BrightSurf.com |